Intagenta 40mg Injection
Intagenta 40mg Injection is an antibiotic used to prevent or treat a wide variety of bacterial infections. This may include infections of the urinary tract, bones and joints, lungs (e.g., pneumonia), brain (e.g., meningitis), sepsis, and some others. However, it is not effective for gonorrhea.
Intagenta 40mg Injection
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Intagenta 40mg Injection is an antibiotic used to prevent or treat a wide variety of bacterial infections. This may include infections of the urinary tract, bones and joints, lungs (e.g., pneumonia), brain (e.g., meningitis), sepsis, and some others. However, it is not effective for gonorrhea.
Intagenta 40mg Injection is an antibiotic used to prevent or treat a wide variety of bacterial infections. This may include infections of the urinary tract, bones and joints, lungs (e.g., pneumonia), brain (e.g., meningitis), sepsis, and some others. However, it is not effective for gonorrhea.
Intagenta 40mg Injection is also widely used in hospitalized patients to prevent infections. It works by stopping the growth of bacteria. It is given as a drip (intravenous infusion) or as an injection directly into a vein or a muscle under the supervision of a healthcare professional. Your doctor may shift you to another antibiotic after culture reports become available. It should be used regularly at evenly spaced time intervals as prescribed by your doctor. Do not skip any doses and finish the full course of treatment even if you feel better. Stopping the medicine too early may lead to the infection returning or worsening.
This medicine may lead to kidney damage and hearing loss as side effects in some patients. Therefore, it is important to follow all the instructions given by your doctor while using this medicine. It may also cause balance disorder (loss of balance) and injection site pain in some people.
Your doctor may monitor you with regular kidney function tests or hearing tests during treatment. Some patients may also be advised to get blood levels of this medicine measured. Before using this medicine, inform your doctor if you are pregnant, planning to become, or breastfeeding.
03Uses
Bacterial infections
04How To Use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
05How It Works
Intagenta 40mg Injection is an antibiotic. It stops bacterial growth by preventing synthesis of essential proteins required by bacteria to carry out vital functions.
06What If You Miss A Dose?
Q: What if you forget to take Intagenta Injection?
A: If you miss a dose of Intagenta 40mg Injection, please consult your doctor.
07Side Effects
Hearing loss
Kidney damage
Balance disorder (loss of balance)
Injection site pain
08Safety Information
Alcohol:SAFE
Consuming alcohol with Intagenta 40mg Injection does not cause any harmful side effects.
Pregnancy:CONSULT YOUR DOCTOR
Intagenta 40mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding:SAFE IF PRESCRIBED
Intagenta 40mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Driving:UNSAFE
Intagenta 40mg Injection may cause side effects which could affect your ability to drive.
Kidney:CAUTION
Intagenta 40mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Intagenta 40mg Injection may be needed. Please consult your doctor.
Liver:CONSULT YOUR DOCTOR
There is limited information available on the use of Intagenta 40mg Injection in patients with liver disease. Please consult your doctor.
References
Sources and references
MacDougall C, Chambers HF. Aminoglycosides. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1515-16.
Chambers HF, Deck DH. Aminoglycosides & Spectinomycin. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 811-12.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 620-22.
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-98. [Accessed 31 Mar. 2019] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). [Accessed 31 Mar. 2019] (online) Available from: View
